The recent CIOMS XIV report is shaping industry perspectives on responsible use of AI in pharmacovigilance — and AB Cube is stepping forward with a fresh, concise analysis of what these principles mean in practice.
Our new 2‑page datasheet breaks down the essentials and highlights how AB Cube’s SafetyEasy® solutions are built for a future where:
- Oversight is risk‑based
- AI performance is benchmarked to humans
- Transparency isn’t optional
- Robustness is the expectation
Access it here: AB Cube CIOMS XIV report analysis